These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 31170730)

  • 1. Reporting Practices on Immunosuppression and Rejection Management in Face Transplantation: A Systematic Review.
    Daneshgaran G; Stern CS; Garfein ES
    J Reconstr Microsurg; 2019 Nov; 35(9):652-661. PubMed ID: 31170730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressive T-cell antibody induction for heart transplant recipients.
    Penninga L; Møller CH; Gustafsson F; Gluud C; Steinbrüchel DA
    Cochrane Database Syst Rev; 2013 Dec; 2013(12):CD008842. PubMed ID: 24297433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experience with steroid-free maintenance immunosuppression in simultaneous pancreas-kidney transplantation.
    Freise CE; Kang SM; Feng S; Posselt A; Hirose K; Hirose R; Stock P
    Transplant Proc; 2004 May; 36(4):1067-8. PubMed ID: 15194370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascularized composite allotransplantation: current standards and novel approaches to prevent acute rejection and chronic allograft deterioration.
    Kueckelhaus M; Fischer S; Seyda M; Bueno EM; Aycart MA; Alhefzi M; ElKhal A; Pomahac B; Tullius SG
    Transpl Int; 2016 Jun; 29(6):655-62. PubMed ID: 26265179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcomes and future challenges in face transplantation.
    Cavaliere A; Rega U; Grimaldi S; Esposito G; Pensato R; D'Andrea F; Longo B; Coiante E; Hersant B; Meningaud JP; La Padula S
    J Plast Reconstr Aesthet Surg; 2024 May; 92():87-103. PubMed ID: 38513344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolutionary experience with immunosuppression in pediatric intestinal transplantation.
    Bond GJ; Mazariegos GV; Sindhi R; Abu-Elmagd KM; Reyes J
    J Pediatr Surg; 2005 Jan; 40(1):274-9; discussion 279-80. PubMed ID: 15868597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Facial transplantation: the first 9 years.
    Khalifian S; Brazio PS; Mohan R; Shaffer C; Brandacher G; Barth RN; Rodriguez ED
    Lancet; 2014 Dec; 384(9960):2153-63. PubMed ID: 24783986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk assessment of immunosuppressive therapy in facial transplantation.
    Vasilic D; Alloway RR; Barker JH; Furr A; Ashcroft R; Banis JC; Kon M; Woodle ES
    Plast Reconstr Surg; 2007 Sep; 120(3):657-668. PubMed ID: 17700117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Face transplantation: on the verge of becoming clinical routine?
    Smeets R; Rendenbach C; Birkelbach M; Al-Dam A; Gröbe A; Hanken H; Heiland M
    Biomed Res Int; 2014; 2014():907272. PubMed ID: 25009821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
    Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of current immunosuppression strategies in renal transplantation on the field of reconstructive transplantation.
    Chang J; Davis CL; Mathes DW
    J Reconstr Microsurg; 2012 Jan; 28(1):7-19. PubMed ID: 21842460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Face Transplantation Update: 2016.
    Sosin M; Rodriguez ED
    Plast Reconstr Surg; 2016 Jun; 137(6):1841-1850. PubMed ID: 27219239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Institutional review board-based recommendations for medical institutions pursuing protocol approval for facial transplantation.
    Siemionow MZ; Gordon CR
    Plast Reconstr Surg; 2010 Oct; 126(4):1232-1239. PubMed ID: 20885245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreas transplant outcomes for United States (US) cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR).
    Gruessner AC; Sutherland DE
    Clin Transpl; 2008; ():45-56. PubMed ID: 19708445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Saving face: The search for alternatives to life-long immunosuppression for face transplants.
    Keener AB
    Nat Med; 2016 May; 22(5):448-9. PubMed ID: 27149211
    [No Abstract]   [Full Text] [Related]  

  • 16. The Consistency and Reporting of Quality-of-Life Outcomes in Trials of Immunosuppressive Agents in Kidney Transplantation: A Systematic Review and Meta-analysis.
    Howell M; Wong G; Turner RM; Tan HT; Tong A; Craig JC; Howard K
    Am J Kidney Dis; 2016 May; 67(5):762-74. PubMed ID: 26724168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of May 2003.
    Gruessner AC; Sutherland DE
    Clin Transpl; 2003; ():21-51. PubMed ID: 15387096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of a single-center experience with mycophenolate mofetil based immunosuppression in renal transplantation.
    Triemer HL; Pearson TC; Odom KL; Larsen CP
    Clin Transplant; 2000 Aug; 14(4 Pt 2):413-20. PubMed ID: 10946781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestine and multivisceral transplantation in the United States: a report of 20-year national registry data (1990-2009).
    Cai J
    Clin Transpl; 2009; ():83-101. PubMed ID: 20524278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current status of liver transplantation in children.
    McDiarmid SV
    Pediatr Clin North Am; 2003 Dec; 50(6):1335-74. PubMed ID: 14710783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.